Evaluation of U-AKIpredTM for Predicting AKI in Critically Ill Patients Within 12 Hours: a Multicenter Prospective Cohort Study
Recruiting
Observational Study
External Effectiveness Validation of Model
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,100 (estimated)
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of our study is to evaluate U-AKIpredTM for predicting AKI in critically ill patients within 12 h by the multicenter prospective cohorts. AKI was diagnosed by Kidney Disease Improving Global Outcomes (KDIGO) criteria. We designed five aspects including the overall fitting effecience evaluation, calibration curve, quantifying calibration performance, quantifying discrimination performance,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* critically ill patients who stayed in ICU for over 24 h;
* patients older than 18 years of age.
Exclusion Criteria:
* patients who admitted in ICU had been diagnosed acute kidney injury;
* patients who admitted in ICU had been diagnosed acute kidney disease;
* patients who a…
Contacts